Efavirenz

Suppliers

Names

[ CAS No. ]:
154598-52-4

[ Name ]:
Efavirenz

[Synonym ]:
Stocrin
EFAVIRNEZ
Efavirenz (200 mg)
(S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(4S)-6-Chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-4H-3,1-benzoxazin-2-ol
(4S)-6-Chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
4H-3,1-Benzoxazin-2-ol, 6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-, (4S)-
DMP 266
SUSTIVA
MDP-266
Efavirenz
2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-

Chemical & Physical Properties

[ Density]:
1.5±0.1 g/cm3

[ Boiling Point ]:
422.7±55.0 °C at 760 mmHg

[ Melting Point ]:
139-141ºC

[ Molecular Formula ]:
C14H9ClF3NO2

[ Molecular Weight ]:
315.675

[ Flash Point ]:
209.4±31.5 °C

[ Exact Mass ]:
315.027405

[ PSA ]:
38.33000

[ LogP ]:
3.72

[ Vapour Pressure ]:
0.0±1.1 mmHg at 25°C

[ Index of Refraction ]:
1.582

Safety Information

[ Symbol ]:

GHS09

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H410

[ Precautionary Statements ]:
P273

[ Hazard Codes ]:
N

[ Risk Phrases ]:
50

[ Safety Phrases ]:
61

[ RIDADR ]:
UN3082 - class 9 - PG 3 - DOT NA1993 - Environmentally hazardous substances, liquid, n.o.s. HI: all (not BR)

[ RTECS ]:
DM3440000

[ HS Code ]:
2942000000

Synthetic Route

Precursor & DownStream

Precursor

  • (S)-carbamic acid cyclopropyl-(2,5-dichloro-phenyl)-trifluoromethyl-prop-2-ynyl ester
  • Triphosgene
  • (S)-1-(2-Amino-5-chlorophenyl)-1-(trifluoromethyl)-3-cyclopropyl-2-propyn-1-ol
  • Diphosgene
  • Diphenyl carbonate
  • N,N-Carbonyldiimidazole
  • [4-Chloro-2-[(1S)-3-cyclopropyl-1-hydroxy-1-(trifluoromethyl)-2-propynyl)phenyl]carbamic Acid Methyl Ester
  • (S)-2-(5-chloro-2-((1S,4R)-4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxamido)phenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-yl 1-chloroethyl carbonate
  • phosgene

DownStream

  • 8-Hydroxy-efavirenz
  • Piperidine

Customs

[ HS Code ]: 2942000000

Articles

Mitochondrial (dys)function - a factor underlying the variability of efavirenz-induced hepatotoxicity?

Br. J. Pharmacol. 172(7) , 1713-27, (2015)

The non-nucleoside analogue reverse transcriptase inhibitor efavirenz is associated with hepatic toxicity and metabolic disturbances. Although the mechanisms involved are not clear, recent evidence ha...

Evaluation of the in vitro/in vivo potential of five berries (bilberry, blueberry, cranberry, elderberry, and raspberry ketones) commonly used as herbal supplements to inhibit uridine diphospho-glucuronosyltransferase.

Food Chem. Toxicol. 72 , 13-9, (2014)

In this study, we evaluated inhibitory potentials of popularly-consumed berries (bilberry, blueberry, cranberry, elderberry, and raspberry ketones) as herbal supplements on UGT1A1, UGT1A4, UGT1A6, UGT...

Evaluation of thein vitro/in vivodrug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition

Food Chem. Toxicol. 68 , 117-27, (2014)

• BST204 is a purified dry extract of ginseng containing high amounts of Rh2 and Rg3. • BST204 had only weak inhibitory effects on nine CYPs and five UGTs. • It is unlikely that BST204 alter pharmacok...


More Articles


Related Compounds

  • Efavirenz
  • Efavirenz-d5
  • ENT Efavirenz
  • rac Efavirenz
  • rac Efavirenz-d4
  • Chloro Efavirenz
  • Methyl 2-(2-chloro-6-fluorophenyl)-2-cyanoacetate
  • Benzyl[(dimethyl-1,3-thiazol-2-YL)methyl]amine
  • 1-(5-Bromo-2-fluorophenyl)butan-1-amine
  • 5-(2-Chloro-4-fluorophenyl)isoxazole-3-carboxylic Acid
  • Benzenemethanol, I+/--(aminomethyl)-I+/--cyclopropyl-3,4-dimethyl-
  • Methyl 2-(3-chlorophenyl)-2-cyanoacetate
  • 1,3-Dioxolane-2-methanamine, 2-(2,5-dimethylphenyl)-
  • 2-(4-(3-Bromophenyl)-1H-pyrazol-1-yl)acetic acid
  • 6-(tert-Butyl)-3-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine
  • 3-(Chloromethyl)-5-(2-naphthalenyl)isoxazole
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.